Pulmonary artery catheterization in acute coronary syndromes: Insights from the GUSTO IIb and GUSTO III trials
Mauricio G. Cohen(Santa Ana College), Christopher B. Granger(Clinical Research Institute), Robert V. Kelly(University of North Carolina at Chapel Hill), E. Magnus Ohman(Tarzana Treatment Centers), Rosana Poggio, Douglas A. Criger(Duke University), Robert M. Califf(Duke University), Venu Menon(Cleveland Clinic), Jorge Ferreira(Universidade do Estado do Amazonas), Monica Shah(Duke University), David F. Kong(Clinical Research Institute), Joel M. Gore(University of Massachusetts Chan Medical School), Karen S. Pieper(Clinical Research Institute)
Cited by 82
Related Papers
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
|New England Journal of Medicine|2019|1.9k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
|Journal of the American College of Cardiology|2016|1.6k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k